`
`http;ligalewayovidcomlremDlserver1lovidweb.cgi
`
`phenomenon, and a slightly greater pressure gradient across the valves than a mechanical valve (MV)
`[Bjork-Shiley monostrut valve]. The flow and pulsatile efficiency were adequate and similar to that of a VAD
`with MVs. In in vitro durability and hemolysis tests, a VAD with STV functioned well for 54 days and showed
`similar hemolytio profiles to a VAD with MVs. In an in vivo acute experiment using an adult sheep. our device
`was problem-free providing sufficient output as a left ventricular assist device (LVAD). Although it will be
`necessary to decrease the pressure gradient across this STV in the future: our device showed efficient
`performance as a practical land cost-effective VAD for short term use.
`
`
`Citation 3.
`
`Unique Identifier
`94272093
`Authors
`
`Sung HW. Tu R. Shen SH. Witzel TH. Lin D. Hata C. Kingsbury CJ. Noishiki Y. Tomizawa Y. Quijano RC.
`Institution
`
`Department of Chemical Engineering. National Center University. Taoyuan. Taiwan. Republic of China.
`
`Title
`
`A newly developed porcine heart valve bioprosthesis fixed with an epoxy compound. An experimental
`evaluation.
`Source
`
`ASAIO Journal. 40(2):192—8. 1994 Apr-Jun.
`Local Messages
`Owned by MU HSL
`Abstract
`
`Concerns with currently available bioprostheses are calcification, long-term durability. and functional and
`hemodynamic performance. It has been well known that these concerns are all more or less related to the
`fixatives. glutaraldehyde or formaldehyde, used in preserving bioprostheses. To address these concerns, we
`undertook the development of a porcine bioprosthesis fixed with an epoxy compound. It was discovered that
`the porcine leaflets fixed with the epoxy compound appeared more natural than those preserved with
`glutaraldehyde. The performance of this newly developed epoxy compound bioprosthesis (three samples) was
`evaluated in a juvenile sheep model. The results were compared to those of its glutaraldehyde counterpart
`(three samples). Two-dimensional echocardiographic inspection of the valvular leaflet motion indicated that the
`epoxy compound leaflets were more pliable than their glutaraldehyde counterparts. In addition, the epoxy
`compound valve appeared to open more widely than the glutaraldehyde valve. Color Doppler flow mapping
`demonstrated that the blood flow distal to the epoxy compound valve was slightly broader than that observed
`distal to the glutaraldehyde valve. Moreover. at retrieval. less calcium and pannus ingrowth were observed in
`the epoxy compound valve than its glutaraldehyde counterpart. The results of this preliminary evaluation
`indicated that the performance of this newly developed epoxy compound valve was at least equivalent to its
`glutaraldehyde counterpart. if not better.
`
`
`
`
`- m. ‘-—
`
`Copyright (Cl 1999W
`Version: 4.1.0 source ID 145821.135. Revision: 1,405.1.4
`
`2 of 2
`
`5l15l'00 12:46 PM
`
`NORRED EXHIBIT 2015 - Page 1
`Medtronic, Inc., Medtronic Vascular, Inc.,
`& Medtronic Corevalve, LLC
`
`v. Troy R. Norred, M.D.
`Case |PR2014-00110
`
`
`
`NORRED EXHIBIT 2015 - Page 2
`
`
`
`2if.
`
`
`
`S/W
`
`
`
`
`mac}hi2:A'Lu’bv5%:
`
`
`
`5gxz
`
`I 5
`
`